Bids Are Invited For Acquisition Of Medicine.

Tender Detail

96323749
105/25/2025
Self-Funded
Bids Are Invited For Acquisition Of Medicine.
NCB
South America
BRIC,G20
20-05-2025

Work Detail

Pharmacological Group: Antineoplastic (Tyrosine Kinase Inhibitor), Active Principle: Nintedanib, Pharmaceutical Form: Capsule, Concentration/Dosage: 150, Unit: Mg, Volume: N/A, Presentation: N/A, Accessory: N/A, Form Supply: Unit

Key Value

Tender Value
Refer document

Attachment

FileName File Description
Global Tender Document Tender Notice
Attachments
Additional Details Available on Click
✓ Tendering Authority
✓ Publication Document
(Tender Document / Tender Notice )
Disclaimer :
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
Tell us about your Product / Services,
We will Find Tenders for you

Copyright © 2025 · All Rights Reserved. Terms of Usage | Privacy Policy

For Tender Information Services Visit : TenderDetail